Benchling

What does it mean to be on #TeamScience? Find out what Benchlings have to say about our mission and culture — and above all, why we’re so passionate about helping scientists power new possibilities for humanity. youtu.be/KiBmXAGoMgU

At @BlueprintMeds, former CEO Kate Haviland brought in over $1.3B in business development transactions. She’s been called Blueprint’s “deals mastermind.” What’s her secret? On #Transcribed, Kate shares how to strategize beyond price and structure partnerships that last. benchling.com/transcribed/ka…

Everyone's talking about #AI. But real, practical guidance on how to use it in the lab is still hard to find. That’s why we started #AIForScientists. We’re bringing together real examples, practical prompts, and honest stories from scientists using AI for R&D, whether they’re using Benchling or not. ✨ See how scientists are actually using AI: benchling.com/ai/ai-for-scie…

#Benchling AI now writes and runs Python in your research workflow. Our Deep Research Agent handles statistical analysis, data transformations, and complex calculations automatically, returns results for review, and logs them to your scientific record. Just describe the chart or analysis you need. Benchling AI does the rest. #AIForScientists ✨

🤖🔬 Lab automation just got easier. Benchling + HighRes now work together to: ✔ Design experiments ✔ Trigger robotic runs ✔ Return analyzed results automatically See how it works: benchling.com/blog/benchling…

How do you turn a failed phase 3 into a blockbuster drug? Kate Haviland, former CEO at @BlueprintMeds, did it with Ayvakit. Instead of abandoning the program, Blueprint went back to the data and bet on a patient population that no one had treated before. On #Transcribed, Kate talks to Benchling CEO @sajithw about navigating clinical setbacks and the strategy that led to a multi-billion dollar Sanofi acquisition.

Kate Haviland, former CEO of @BlueprintMeds, and her team turned an expensive Phase 3 failure into Ayvakit, a first-in-class therapy for systemic mastocytosis. On this episode of Transcribed, Kate takes us inside the company-defining pivot from oncology to immunology that ultimately led to Ayvakit and a $9.5B acquisition by @sanofi. I hope you enjoy this episode of Transcribed, which was recorded live in front of 500 scientists.

Still spending too much time on lab documentation? Here’s how #AI can help: ✔️ Transcribe kit protocols into Benchling templates ✔️ Turn whiteboard sketches into structured experiment entries ✔️ Clone past experiments and modify sample counts/controls ✔️ Import CRO data and notes into entries simultaneously Learn how: benchling.com/blog/4-ways-to… #AIForScientists ✨

There has been no shortage of excitement about CRISPR, but turning it into medicines has been slower and harder than many expected. @janiceschen, cofounder & CSO at @mammothbiosci, isn’t fazed. As a grad student in Jennifer Doudna’s lab, Janice helped shape early conversations around CRISPR. Eight years in, she sees a path to eradicating certain genetic diseases. On Transcribed, Janice and I talk about expanding the CRISPR toolkit, proving real-world utility, and building when science outpaces the system. Plus, the story of how Jennifer challenged her to aim higher and start her own company.

@janiceschen @mammothbiosci @sajithw 🎙️ Watch the full conversation. benchling.com/transcribed/ja…

🧬 What if we could eradicate certain rare genetic diseases, like we did for infectious diseases such as smallpox? @janiceschen, cofounder and CSO at @mammothbiosci, thinks #CRISPR could do it in the next 10 years. On #Transcribed, Janice talks to Benchling CEO @sajithw about founding Mammoth straight out of the Doudna Lab, why the biggest barriers to gene editing aren't scientific, and how they developed a COVID test in days.

Your lab meeting just ended and your PI’s whiteboard sketch needs to become a proper notebook entry. You could transcribe it from photos and scattered notes... or just let #AI handle it. We show exactly how, with copy-paste prompts: benchling.com/blog/4-ways-to… #AIForScientists ✨

Tired of re-explaining context to #AI agents? With Custom Instructions in #BenchlingAI, set your preferences once — and get responses tailored to your workflows and requirements every time. Try it out and see the difference personalized context makes. #AIForScientists

When people ask "How can we make #AAV #GeneTherapy accessible and affordable" --> this is how 👇

🎙️ Watch @Nicole_Paulk explain universal gene therapy (and much more) on #Transcribed. benchling.com/transcribed/ni…

💉 “What if you could make a gene therapy that could treat 2 or 200 diseases with the exact same drug product. Could that be possible?” Congrats @Nicole_Paulk on @SirenBio’s second IND clearance!! 🎉

✨ @mammothbiosci cut hours of preclinical data entry down to minutes with #BenchlingAI. What used to require writing custom Jupyter notebooks to ingest Excel files from CROs now takes 10 minutes and natural language prompts — no code needed. #BuiltOnBenchling #AIForScientists

At @lifeschemistry, non-clinical reports used to take weeks. With #BenchlingAI, teams can now generate draft reports in a day — directly from experimental records. ✔️ Drafts 400% faster ✔️ One reporting workflow across US + India teams ✔️ Data stays secure (no exporting) How they did it 👉 benchling.com/blog/enveda-re… #BuiltOnBenchling #AIForScientists

"The centrifuge was run at 5000 rpm for five minutes, with a stuffed cow placed on top to keep it happy." 🐮 Don’t worry, you’re not the only one who does it. reddit.com/r/labrats/comm… Happy #Fridaythe13th to the most logical yet superstitious people we know: scientists!

Which lab superstitions are you guilty of? 👻🧪 #Fridaythe13th #LabLife